Drug delivery systems

ReportsandReports – Drug Delivery Markets Implantable Injectable ...

by research

Kalorama’s Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems , the second volume of Kalorama’s popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for... Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players Current Market Size and Forecasts to 2013 Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other... With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the pharmaceutical industry. Drug Delivery Techology Revenues Pharmaceuticals Sold via Delivery Technology This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. pSivida SurModics, Inc Zogenix Corporation AP Pharma Baxter BioPharma Solutions QLT USA, Inc Ypsomed Holding AG Kalorama has also published Drug Delivery Markets: Oral Delivery, Provides detail for business planners on the market for implantable / injectable delivery system markets. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:. Needle-free drug delivery Other Injectable/Implantable Kalorama’s unique analysis offers segmentation of this market for:. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:. This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Biopharmaceutical products are driving growth of needle-free systems. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders. MGI Pharma, Inc Nektar Therapeutics Pacira Pharmaceuticals, Inc. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. Kalorama considers these seperate markets). Companies Profiled in the report include:. Antares Pharma, Inc.

Source: ReportsandReports – Drug Delivery Markets Implantable Injectable ...

Polymeric Drug Delivery Systems - Biomaterials - UND Engineering

New Comprehensive Research Reports by Visiongain Published by MarketPublishers.com

18.07.11

Statins: World Market Outlook 2011-2021. In 2009 the world statins market generated over $27bn in revenues. From 2011 to 2021 the patent expiries of Lipitor (atorvastatin) and Crestor (rosuvastatin) will lead to rising generic competition. The overall branded statins market looks set to decline. The study offers a deep insight into the present market situation, gives an in-depth overall analysis and features detailed forecasts … http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/statins_world_market_outlook_2011_2021.html

US Pharmaceutical Market Outlook 2011-2021. The study delves into discussions for the top drugs in the US market and profiles the US market's leading players, with analyses of their growth strategies. It covers their plans to expand and diversify their portfolios, restructure their operations and consolidate positions in emerging markets. The study provides revenue forecasts for the top companies in the US market and worldwide … http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/us_pharmaceutical_market_outlook_2011_2021.html

Source: TMC Net

what role can the technique of weak-acid titration play in the development of new drug delivery systems?

Mar 07, 2010 by shyla | Posted in Chemistry

(gen chem 2)
Thank you:)
SS68Blue:
how does weak acid titration help simulate the ability of the body to absorb the drug in different areas of the body?
thank you.

Weak-acid titration can help simulate the ability of the body to absorb the drug in different areas of the body as well as the affect of acid on the active ingredient(s) in the drug.

This information would be critical in the development

ss68blue | Mar 07, 2010

Weak-acid titration can help simulate the ability of the body to absorb the drug in different areas of the body as well as the affect of acid on the active ingredient(s) in the drug.

This information would be critical in the development

ss68blue | Mar 07, 2010

what are the Issues and challenges in developing ruminal drug delivery systems?

Jan 12, 2010 by lisa mony | Posted in Small Business

Ruminants have a specialised digestive system that contains anaerobic bacteria and protozoa capable of digesting the
cellulosic materials that are so common in plant materials. In addition, their distinct digestive system can change the metabolism

You have posted your question in the small business section. May I suggest another location

jwishz | Jan 15, 2010